Sustained high trough factor IX activity levels with continued use of rIX‐FP in adult and paediatric patients with haemophilia B

Ítems similars

• Health‐related quality of life in paediatric haemophilia B patients treated with rIX‐FP
  per: von Mackensen, Sylvia, et al.
  Publicat: (2018)
• High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice
  per: Mancuso, Maria Elisa, et al.
  Publicat: (2020)
• Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial
  per: Santagostino, Elena, et al.
  Publicat: (2016)
• Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis
  per: Hermans, Cedric, et al.
  Publicat: (2020)
• Long-Acting Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Children: Results of a Phase 3 Trial
  per: Kenet, Gili, et al.
  Publicat: (2016)